Volume Resuscitation in Cirrhosis With Sepsis Induced Hypotension
Key facts
- Who runs it
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Where
- India2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 350 people enrolled
- Started
- 1 Feb 2020
- Ended
- 10 Aug 2025
- Type of study
- Observational
- Treatments tested
- Albumin + electrolyte solution
- POCUS guided fluid resuscitation
- Record updated
- 2 September 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Clinical/Imaging or Biopsy proven liver cirrhosis of any etiology
- Hypotension (MAP <65mmHg or SBP <90mmHg)
- 18-65 yrs of age
Who cannot take part
- Already received colloid or 2 litres of fluid within the first 2 hours of presentation, without echocardiographic assessment
- Severe pre-existing cardiopulmonary disease
- Acute Respiratory Distress Syndrome (ARDS)
- Active bleeding like variceal bleed 28
- Chronic renal disease - End Stage Renal Disease (ESRD)/ patient on renal replacement therapy
- Admission to ICU following liver transplantation, burns, cardiac surgery
- Previous adverse reaction to human albumin solution
- Already on vasopressors/inotropes
- Cerebrovascular events
- Brain death or likely brain death within 24 hours
- Pregnant or lactating women
- Informed consent refused by patient or attendants
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In critically ill patients with liver disease like cirrhosis or ACLF, fluid therapy needs to be instituted after identification of patients who will be fluid responsive and initiate appropriate inotropes early to prevent the mortality associated with fluid overload.
Read full original descriptionShow less
The parameters and methodology used for assessing fluid responsiveness have been studied earlier, but the optimum method is not established. Existing recommendations based on data regarding fluid responsiveness and choice of fluid for resuscitation from intensive care units in general cannot be applied to those with liver disease as the hemodynamic alterations that occur with liver disease, presence of hypoalbuminemia at baseline and presence of cardiac dysfunction interfere with the conventional methods of fluid status assessment, fluid responsiveness as well as the response to different types of resuscitation fluids.
Therefore the investigators attempt to compare various methods to estimate current intravascular volume status of patient which could be helpful in guiding fluid therapy.
The group in the trial
- Cirrhosis/ACLF of any etiology
Treatment: Albumin + electrolyte solution and POCUS guided fluid resuscitation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- To Compare the Effectiveness of Various Methods of Estimating Volume Resuscitation in Patients With Cirrhosis With Sepsis Induced Hypotension
- Record updated
- 2 September 2025